Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H&R GmbH KGaALTS:0RRC 65 EBIT per Share is €-0.55 as of Mar. 2026. GuruFocus rates LTS:0RRC with a GF Score™ of 65/100 and a GF Value™ of €4.24 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,338 Chemicals companies, H&R GmbH KGaA ranks worse than 83.33% on this metric.
H&R GmbH KGaA's EBIT per Share for the
three
months ended in Mar. 2026 was €0.25.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.55.
During the past 12 months, the average EBIT per Share Growth Rate of H&R GmbH KGaA was -15.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -28.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for H&R GmbH KGaA's EBIT per Share or its related term are showing as below:
LTS:0RRC'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -64.1 Med: -3.8 Max: 139.5
Current: -28.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of H&R GmbH KGaA was 139.50% per year. The lowest was -64.10% per year. And the median was -3.80% per year.
LTS:0RRC's 3-Year EBIT Growth Rate is ranked worse than 83.33% of 1338
companies
in the Chemicals industry
Industry Median: -1.15
vs LTS:0RRC: -28.60
H&R GmbH KGaA's EBIT for the
three
months ended in Mar. 2026 was €10 Mil.
H&R GmbH KGaA (LTS:0RRC) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
H&R GmbH KGaA EBIT per Share Related Terms
H&R GmbH KGaA EBIT per Share Historical Data
* Premium members only.
The historical data trend for H&R GmbH KGaA's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.55
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H&R GmbH KGaA (LTS:0RRC) has a EBIT per Share of €-0.55 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on H&R GmbH KGaA and its competitors. According to the industry distribution chart, H&R GmbH KGaA ranks #1115 out of 1338 companies in the Chemicals industry, placing it in the top 83.3%.
Is H&R GmbH KGaA's EBIT per Share too high?
H&R GmbH KGaA's current EBIT per Share is €-0.55. Based on the distribution chart, H&R GmbH KGaA ranks #1115 out of 1338 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, H&R GmbH KGaA has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's EBIT per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, H&R GmbH KGaA ranks #1115 out of 1338 companies for EBIT per Share. This places H&R GmbH KGaA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on H&R GmbH KGaA and its competitors. H&R GmbH KGaA's current EBIT per Share is €-0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (LTS:0RRC) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.24, compared to a current price of €6.44 — trading 51.9% above its estimated fair value. The current EBIT per Share is €-0.55. H&R GmbH KGaA's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For H&R GmbH KGaA (LTS:0RRC), the current EBIT per Share is €-0.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H&R GmbH KGaA (LTS:0RRC) Overvalued in 2026?
Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued.
The current stock price of €6.44 is trading 51.9% above its estimated GF Value™ of €4.24.
GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.
Key valuation signals for LTS:0RRC:
EBIT per Share: €-0.55
GF Value™: €4.24 vs. price of €6.44 (51.9% above fair value)
No single metric tells the full story. See the LTS:0RRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
65GF Score
Get the complete analysis for LTS:0RRC
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RRC has been successfully added to your 
